Go Pro
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel Free SABS Stock Alerts

SAB Biotherapeutics (SABS) Stock Chart & Stock Price History

SAB Biotherapeutics logo
$3.41 -0.01 (-0.29%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.53 +0.12 (+3.52%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SAB Biotherapeutics Stock Price Performance

The SAB Biotherapeutics (SABS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 60.85%, with a year-to-date return of -8.82%. In the past month, the stock has decreased 10.26%, reflecting recent market activity.

As of the latest close, SAB Biotherapeutics traded at $3.41 with a market cap of $310.28 million and volume of 712,046 shares.

Receive SABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-8.33%
1 Month
Performance
-10.26%
3 Month
Performance
+2.40%
Year-To-Date
Performance
-8.82%
1 Year
Performance
+60.85%

SABS Stock Chart for Saturday, September, 12, 2026

SABS Chart by TradingView

SAB Biotherapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/11/2026$3.42$3.41
-0.29%		$3.54$3.38712,046 shs$310.28 million
09/10/2026$3.48$3.42
-1.72%		$3.53$3.40328,624 shs$311.19 million
09/09/2026$3.63$3.48
-4.13%		$3.65$3.47200,973 shs$316.63 million
09/08/2026$3.72$3.63
-2.42%		$3.75$3.62171,264 shs$330.29 million
09/07/2026$3.72$3.72$3.75$3.70110,632 shs$338.48 million
09/04/2026$3.72$3.72$3.75$3.70110,632 shs$338.48 million
09/03/2026$3.75$3.72
-0.80%		$3.79$3.71161,591 shs$338.47 million
09/02/2026$3.70$3.75
+1.35%		$3.77$3.60300,419 shs$341.21 million
09/01/2026$3.71$3.70
-0.27%		$3.75$3.65202,281 shs$336.66 million
08/31/2026$3.79$3.71
-2.11%		$3.80$3.69201,143 shs$337.56 million
08/28/2026$3.93$3.79
-3.56%		$3.99$3.79202,596 shs$344.84 million
08/27/2026$3.88$3.93
+1.29%		$3.93$3.84282,217 shs$357.59 million
08/26/2026$3.81$3.88
+1.84%		$3.90$3.75274,418 shs$353.04 million
08/25/2026$3.62$3.81
+5.25%		$3.81$3.61359,283 shs$346.66 million
08/24/2026$3.78$3.62
-4.23%		$3.78$3.61602,371 shs$329.38 million
08/21/2026$3.70$3.78
+2.16%		$3.83$3.70195,668 shs$343.94 million
08/20/2026$3.78$3.70
-2.12%		$3.76$3.66229,617 shs$336.66 million
08/19/2026$3.79$3.78
-0.26%		$3.88$3.76701,252 shs$343.94 million
08/18/2026$3.77$3.79
+0.53%		$3.82$3.67351,098 shs$344.85 million
08/17/2026$3.70$3.77
+1.89%		$3.85$3.69232,027 shs$343.03 million
08/14/2026$3.75$3.70
-1.33%		$3.78$3.68324,201 shs$336.66 million
08/13/2026$3.80$3.75
-1.32%		$3.84$3.74256,452 shs$341.21 million
08/12/2026$3.76$3.80
+1.06%		$3.83$3.70307,681 shs$345.76 million
08/11/2026$3.78$3.76
-0.53%		$3.79$3.67311,937 shs$342.12 million
Related Companies

This page (NASDAQ:SABS) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)
Don't buy Nvidia... Not when the AI companies that will define the next decade are selling for pennies. You wo...
Decentralized Masters | Sponsoredtc pixel
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
This 38 Dollar Fund Holds Every Major AI Stock and Pays Weekly
The biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...
Investors Alley | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel